Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > By political borders only, yes, the U.S. has fallen way
View:
Post by subaru1i on Mar 30, 2024 9:06am

By political borders only, yes, the U.S. has fallen way

behind other countries in the development of cannabinoid pharmacueticals.   Merely look at the number of published papers globally, China now coming on strong in advance research work.   Fortunately the science was carried over from work at Technion in Israel into Canada and carried on from there, academic research (Israel) into application (Canada, clinical trials).   

Interestingly enough, the Stockhouse report on Germany that mentioned LABS I believe also mentioned Avicanna as a 'spin off' from J&J's JLABS.   

JLABS was established in 2016 in Toronto but Medipharm Labs was already ahead of them being established 'publicly' in 2015 (Pfizer got the jump)
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities